Propofol is an intravenous anaesthetic agent used for induction and maintenance of general anaesthesia. IV administration of propfol is used to induce unconsciousness after which anaesthesia may be maintained using a combination of medications. Recovery from propofol-induced anaesthesia is generally rapid and associated with less frequent side effects (e.g. drowsiness, nausea, vomiting) than with thiopental, methohexital, and etomidate. Propofol may be used prior to diagnostic procedures requiring anaesthesia, in the management of refractory status epilepticus, and for induction and/or maintenance of anaesthesia prior to and during surgeries.
Used for induction and/or maintenance of anaesthesia and for management of refractory status epilepticus.
Aalborg Hospital, 4th. dept of Anaesthesiology, Division for Ear Nose and Troath anaesthesia, Aalborg, Nord Jylland, Denmark
UMDNJ-University Hospital, Newark, New Jersey, United States
MUHC - Montreal General Hospital, Montreal, Quebec, Canada
The University of Chicago, Chicago, Illinois, United States
University of Maryland Medical Center, Baltimore, Maryland, United States
UMDNJ-University Hospital, Newark, New Jersey, United States
University Hospital, Newark, New Jersey, United States
Aretaieio Hospital, University of Athens, Athens, Attiki, Greece
Hennepin County Medical Center, Minneapolis, Minnesota, United States
Hennepin County Medical Center, Minneapolis, Minnesota, United States
Hennepin County Medical Center, Minneapolis, Minnesota, United States
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.